Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 49 entries
Sorted by: Best Match Show Resources per page
Enriched biodiversity data as a resource and service.

Biodiversity data journal

Vos RA, Biserkov JV, Balech B, Beard N, Blissett M, Brenninkmeijer C, van Dooren T, Eades D, Gosline G, Groom QJ, Hamann TD, Hettling H, Hoehndorf R, Holleman A, Hovenkamp P, Kelbert P, King D, Kirkup D, Lammers Y, DeMeulemeester T, Mietchen D, Miller JA, Mounce R, Nicolson N, Page R, Pawlik A, Pereira S, Penev L, Richards K, Sautter G, Shorthouse DP, Tähtinen M, Weiland C, Williams AR, Sierra S.
PMID: 25057255
Biodivers Data J. 2014 Jun 16;(2):e1125. doi: 10.3897/BDJ.2.e1125. eCollection 2014.

BACKGROUND: Recent years have seen a surge in projects that produce large volumes of structured, machine-readable biodiversity data. To make these data amenable to processing by generic, open source "data enrichment" workflows, they are increasingly being represented in a...

Cite
Vos RA, Biserkov JV, Balech B, et al. Enriched biodiversity data as a resource and service. Biodivers Data J. 2014;(2):e1125doi: 10.3897/BDJ.2.e1125.
Vos, R. A., Biserkov, J. V., Balech, B., Beard, N., Blissett, M., Brenninkmeijer, C., van Dooren, T., Eades, D., Gosline, G., Groom, Q. J., Hamann, T. D., Hettling, H., Hoehndorf, R., Holleman, A., Hovenkamp, P., Kelbert, P., King, D., Kirkup, D., Lammers, Y., DeMeulemeester, T., Mietchen, D., Miller, J. A., Mounce, R., Nicolson, N., Page, R., Pawlik, A., Pereira, S., Penev, L., Richards, K., Sautter, G., Shorthouse, D. P., Tähtinen, M., Weiland, C., Williams, A. R., & Sierra, S. (2014). Enriched biodiversity data as a resource and service. Biodiversity data journal, (2), e1125. https://doi.org/10.3897/BDJ.2.e1125
Vos, Rutger Aldo, et al. "Enriched biodiversity data as a resource and service." Biodiversity data journal vol. ,2 (2014): e1125. doi: https://doi.org/10.3897/BDJ.2.e1125
Vos RA, Biserkov JV, Balech B, Beard N, Blissett M, Brenninkmeijer C, van Dooren T, Eades D, Gosline G, Groom QJ, Hamann TD, Hettling H, Hoehndorf R, Holleman A, Hovenkamp P, Kelbert P, King D, Kirkup D, Lammers Y, DeMeulemeester T, Mietchen D, Miller JA, Mounce R, Nicolson N, Page R, Pawlik A, Pereira S, Penev L, Richards K, Sautter G, Shorthouse DP, Tähtinen M, Weiland C, Williams AR, Sierra S. Enriched biodiversity data as a resource and service. Biodivers Data J. 2014 Jun 16;(2):e1125. doi: 10.3897/BDJ.2.e1125. eCollection 2014. PMID: 25057255; PMCID: PMC4092319.
Copy Download .nbib Format: NLM
Unusual high blood glucose in ketoacidosis as first presentation of type 1 diabetes mellitus.

Endocrinology, diabetes & metabolism case reports

Hörber S, Hudak S, Kächele M, Overkamp D, Fritsche A, Häring HU, Peter A, Heni M.
PMID: 30306778
Endocrinol Diabetes Metab Case Rep. 2018 Sep 25;2018. doi: 10.1530/EDM-18-0094.

Diabetic ketoacidosis is a life-threatening complication of diabetes mellitus. It usually occurs in patients with type 1 diabetes where it is typically associated with only moderately increased blood glucose. Here, we report the case of a 52-year-old female patient...

Cite
Hörber S, Hudak S, Kächele M, et al. Unusual high blood glucose in ketoacidosis as first presentation of type 1 diabetes mellitus. Endocrinol Diabetes Metab Case Rep. 2018;2018doi: 10.1530/EDM-18-0094.
Hörber, S., Hudak, S., Kächele, M., Overkamp, D., Fritsche, A., Häring, H. U., Peter, A., & Heni, M. (2018). Unusual high blood glucose in ketoacidosis as first presentation of type 1 diabetes mellitus. Endocrinology, diabetes & metabolism case reports, 2018. https://doi.org/10.1530/EDM-18-0094
Hörber, Sebastian, et al. "Unusual high blood glucose in ketoacidosis as first presentation of type 1 diabetes mellitus." Endocrinology, diabetes & metabolism case reports vol. 2018 (2018). doi: https://doi.org/10.1530/EDM-18-0094
Hörber S, Hudak S, Kächele M, Overkamp D, Fritsche A, Häring HU, Peter A, Heni M. Unusual high blood glucose in ketoacidosis as first presentation of type 1 diabetes mellitus. Endocrinol Diabetes Metab Case Rep. 2018 Sep 25;2018. doi: 10.1530/EDM-18-0094. PMID: 30306778; PMCID: PMC6169544.
Copy Download .nbib Format: NLM
The Impact of the Extent of Surgery on the Long-Term Outcomes of Patients with Low-Risk Differentiated Non-Medullary Thyroid Cancer: A Systematic Meta-Analysis.

Journal of clinical medicine

Bojoga A, Koot A, Bonenkamp J, de Wilt J, IntHout J, Stalmeier P, Hermens R, Smit J, Ottevanger P, Netea-Maier R.
PMID: 32708218
J Clin Med. 2020 Jul 21;9(7). doi: 10.3390/jcm9072316.

Recently, the management of patients with low-risk differentiated non-medullary thyroid cancer (DTC), including papillary and follicular thyroid carcinoma subtypes, has been critically appraised, questioning whether these patients might be overtreated without a clear clinical benefit. The American Thyroid Association...

Cite
Bojoga A, Koot A, Bonenkamp J, et al. The Impact of the Extent of Surgery on the Long-Term Outcomes of Patients with Low-Risk Differentiated Non-Medullary Thyroid Cancer: A Systematic Meta-Analysis. J Clin Med. 2020;9(7)doi: 10.3390/jcm9072316.
Bojoga, A., Koot, A., Bonenkamp, J., de Wilt, J., IntHout, J., Stalmeier, P., Hermens, R., Smit, J., Ottevanger, P., & Netea-Maier, R. (2020). The Impact of the Extent of Surgery on the Long-Term Outcomes of Patients with Low-Risk Differentiated Non-Medullary Thyroid Cancer: A Systematic Meta-Analysis. Journal of clinical medicine, 9(7), . https://doi.org/10.3390/jcm9072316
Bojoga, Andreea, et al. "The Impact of the Extent of Surgery on the Long-Term Outcomes of Patients with Low-Risk Differentiated Non-Medullary Thyroid Cancer: A Systematic Meta-Analysis." Journal of clinical medicine vol. 9,7 (2020). doi: https://doi.org/10.3390/jcm9072316
Bojoga A, Koot A, Bonenkamp J, de Wilt J, IntHout J, Stalmeier P, Hermens R, Smit J, Ottevanger P, Netea-Maier R. The Impact of the Extent of Surgery on the Long-Term Outcomes of Patients with Low-Risk Differentiated Non-Medullary Thyroid Cancer: A Systematic Meta-Analysis. J Clin Med. 2020 Jul 21;9(7). doi: 10.3390/jcm9072316. PMID: 32708218; PMCID: PMC7408649.
Copy Download .nbib Format: NLM
The Dutch Data Warehouse, a multicenter and full-admission electronic health records database for critically ill COVID-19 patients.

Critical care (London, England)

Fleuren LM, Dam TA, Tonutti M, de Bruin DP, Lalisang RCA, Gommers D, Cremer OL, Bosman RJ, Rigter S, Wils EJ, Frenzel T, Dongelmans DA, de Jong R, Peters M, Kamps MJA, Ramnarain D, Nowitzky R, Nooteboom FGCA, de Ruijter W, Urlings-Strop LC, Smit EGM, Mehagnoul-Schipper DJ, Dormans T, de Jager CPC, Hendriks SHA, Achterberg S, Oostdijk E, Reidinga AC, Festen-Spanjer B, Brunnekreef GB, Cornet AD, van den Tempel W, Boelens AD, Koetsier P, Lens J, Faber HJ, Karakus A, Entjes R, de Jong P, Rettig TCD, Arbous S, Vonk SJJ, Fornasa M, Machado T, Houwert T, Hovenkamp H, Noorduijn-Londono R, Quintarelli D, Scholtemeijer MG, de Beer AA, Cina G, Beudel M, Herter WE, Girbes ARJ, Hoogendoorn M, Thoral PJ, Elbers PWG.
PMID: 34425864
Crit Care. 2021 Aug 23;25(1):304. doi: 10.1186/s13054-021-03733-z.

BACKGROUND: The Coronavirus disease 2019 (COVID-19) pandemic has underlined the urgent need for reliable, multicenter, and full-admission intensive care data to advance our understanding of the course of the disease and investigate potential treatment strategies. In this study, we...

Cite
Fleuren LM, Dam TA, Tonutti M, et al. The Dutch Data Warehouse, a multicenter and full-admission electronic health records database for critically ill COVID-19 patients. Crit Care. 2021;25(1):304doi: 10.1186/s13054-021-03733-z.
Fleuren, L. M., Dam, T. A., Tonutti, M., de Bruin, D. P., Lalisang, R. C. A., Gommers, D., Cremer, O. L., Bosman, R. J., Rigter, S., Wils, E. J., Frenzel, T., Dongelmans, D. A., de Jong, R., Peters, M., Kamps, M. J. A., Ramnarain, D., Nowitzky, R., Nooteboom, F. G. C. A., de Ruijter, W., Urlings-Strop, L. C., Smit, E. G. M., Mehagnoul-Schipper, D. J., Dormans, T., de Jager, C. P. C., Hendriks, S. H. A., Achterberg, S., Oostdijk, E., Reidinga, A. C., Festen-Spanjer, B., Brunnekreef, G. B., Cornet, A. D., van den Tempel, W., Boelens, A. D., Koetsier, P., Lens, J., Faber, H. J., Karakus, A., Entjes, R., de Jong, P., Rettig, T. C. D., Arbous, S., Vonk, S. J. J., Fornasa, M., Machado, T., Houwert, T., Hovenkamp, H., Noorduijn-Londono, R., Quintarelli, D., Scholtemeijer, M. G., de Beer, A. A., Cina, G., Beudel, M., Herter, W. E., Girbes, A. R. J., Hoogendoorn, M., Thoral, P. J., & Elbers, P. W. G. (2021). The Dutch Data Warehouse, a multicenter and full-admission electronic health records database for critically ill COVID-19 patients. Critical care (London, England), 25(1), 304. https://doi.org/10.1186/s13054-021-03733-z
Fleuren, Lucas M, et al. "The Dutch Data Warehouse, a multicenter and full-admission electronic health records database for critically ill COVID-19 patients." Critical care (London, England) vol. 25,1 (2021): 304. doi: https://doi.org/10.1186/s13054-021-03733-z
Fleuren LM, Dam TA, Tonutti M, de Bruin DP, Lalisang RCA, Gommers D, Cremer OL, Bosman RJ, Rigter S, Wils EJ, Frenzel T, Dongelmans DA, de Jong R, Peters M, Kamps MJA, Ramnarain D, Nowitzky R, Nooteboom FGCA, de Ruijter W, Urlings-Strop LC, Smit EGM, Mehagnoul-Schipper DJ, Dormans T, de Jager CPC, Hendriks SHA, Achterberg S, Oostdijk E, Reidinga AC, Festen-Spanjer B, Brunnekreef GB, Cornet AD, van den Tempel W, Boelens AD, Koetsier P, Lens J, Faber HJ, Karakus A, Entjes R, de Jong P, Rettig TCD, Arbous S, Vonk SJJ, Fornasa M, Machado T, Houwert T, Hovenkamp H, Noorduijn-Londono R, Quintarelli D, Scholtemeijer MG, de Beer AA, Cina G, Beudel M, Herter WE, Girbes ARJ, Hoogendoorn M, Thoral PJ, Elbers PWG. The Dutch Data Warehouse, a multicenter and full-admission electronic health records database for critically ill COVID-19 patients. Crit Care. 2021 Aug 23;25(1):304. doi: 10.1186/s13054-021-03733-z. PMID: 34425864; PMCID: PMC8381710.
Copy Download .nbib Format: NLM
Morpho-Molecular Metabolic Analysis and Classification of Human Pituitary Gland and Adenoma Biopsies Based on Multimodal Optical Imaging.

Cancers

Giardina G, Micko A, Bovenkamp D, Krause A, Placzek F, Papp L, Krajnc D, Spielvogel CP, Winklehner M, Höftberger R, Vila G, Andreana M, Leitgeb R, Drexler W, Wolfsberger S, Unterhuber A.
PMID: 34209497
Cancers (Basel). 2021 Jun 29;13(13). doi: 10.3390/cancers13133234.

Pituitary adenomas count among the most common intracranial tumors. During pituitary oncogenesis structural, textural, metabolic and molecular changes occur which can be revealed with our integrated ultrahigh-resolution multimodal imaging approach including optical coherence tomography (OCT), multiphoton microscopy (MPM) and...

Cite
Giardina G, Micko A, Bovenkamp D, et al. Morpho-Molecular Metabolic Analysis and Classification of Human Pituitary Gland and Adenoma Biopsies Based on Multimodal Optical Imaging. Cancers (Basel). 2021;13(13)doi: 10.3390/cancers13133234.
Giardina, G., Micko, A., Bovenkamp, D., Krause, A., Placzek, F., Papp, L., Krajnc, D., Spielvogel, C. P., Winklehner, M., Höftberger, R., Vila, G., Andreana, M., Leitgeb, R., Drexler, W., Wolfsberger, S., & Unterhuber, A. (2021). Morpho-Molecular Metabolic Analysis and Classification of Human Pituitary Gland and Adenoma Biopsies Based on Multimodal Optical Imaging. Cancers, 13(13), . https://doi.org/10.3390/cancers13133234
Giardina, Gabriel, et al. "Morpho-Molecular Metabolic Analysis and Classification of Human Pituitary Gland and Adenoma Biopsies Based on Multimodal Optical Imaging." Cancers vol. 13,13 (2021). doi: https://doi.org/10.3390/cancers13133234
Giardina G, Micko A, Bovenkamp D, Krause A, Placzek F, Papp L, Krajnc D, Spielvogel CP, Winklehner M, Höftberger R, Vila G, Andreana M, Leitgeb R, Drexler W, Wolfsberger S, Unterhuber A. Morpho-Molecular Metabolic Analysis and Classification of Human Pituitary Gland and Adenoma Biopsies Based on Multimodal Optical Imaging. Cancers (Basel). 2021 Jun 29;13(13). doi: 10.3390/cancers13133234. PMID: 34209497; PMCID: PMC8267638.
Copy Download .nbib Format: NLM
Support and stability.

Cladistics : the international journal of the Willi Hennig Society

Hovenkamp P.
PMID: 34879604
Cladistics. 2009 Apr;25(2):107-108. doi: 10.1111/j.1096-0031.2008.00243.x. Epub 2009 Mar 23.

No abstract available.

Cite
Hovenkamp P. Support and stability. Cladistics. 2009;25(2):107-108doi: 10.1111/j.1096-0031.2008.00243.x.
Hovenkamp, P. (2009). Support and stability. Cladistics : the international journal of the Willi Hennig Society, 25(2), 107-108. https://doi.org/10.1111/j.1096-0031.2008.00243.x
Hovenkamp, P. "Support and stability." Cladistics : the international journal of the Willi Hennig Society vol. 25,2 (2009): 107-108. doi: https://doi.org/10.1111/j.1096-0031.2008.00243.x
Hovenkamp P. Support and stability. Cladistics. 2009 Apr;25(2):107-108. doi: 10.1111/j.1096-0031.2008.00243.x. Epub 2009 Mar 23. PMID: 34879604.
Copy Download .nbib Format: NLM
Repeatability and Reproducibility of ADC Measurements and MRI Signal Intensity Measurements of Bone Marrow in Monoclonal Plasma Cell Disorders: A Prospective Bi-institutional Multiscanner, Multiprotocol Study.

Investigative radiology

Wennmann M, Thierjung H, Bauer F, Weru V, Hielscher T, Grözinger M, Gnirs R, Sauer S, Goldschmidt H, Weinhold N, Bonekamp D, Schlemmer HP, Weber TF, Delorme S, Rotkopf LT.
PMID: 34839306
Invest Radiol. 2021 Nov 23; doi: 10.1097/RLI.0000000000000838. Epub 2021 Nov 23.

BACKGROUND/OBJECTIVES: Apparent diffusion coefficient (ADC) and signal intensity (SI) measurements play an increasing role in magnetic resonance imaging (MRI) of monoclonal plasma cell disorders. The purpose of this study was to assess interrater variability, repeatability, and reproducibility of ADC...

Cite
Wennmann M, Thierjung H, Bauer F, et al. Repeatability and Reproducibility of ADC Measurements and MRI Signal Intensity Measurements of Bone Marrow in Monoclonal Plasma Cell Disorders: A Prospective Bi-institutional Multiscanner, Multiprotocol Study. Invest Radiol. 2021;doi: 10.1097/RLI.0000000000000838.
Wennmann, M., Thierjung, H., Bauer, F., Weru, V., Hielscher, T., Grözinger, M., Gnirs, R., Sauer, S., Goldschmidt, H., Weinhold, N., Bonekamp, D., Schlemmer, H. P., Weber, T. F., Delorme, S., & Rotkopf, L. T. (2021). Repeatability and Reproducibility of ADC Measurements and MRI Signal Intensity Measurements of Bone Marrow in Monoclonal Plasma Cell Disorders: A Prospective Bi-institutional Multiscanner, Multiprotocol Study. Investigative radiology, . https://doi.org/10.1097/RLI.0000000000000838
Wennmann, Markus, et al. "Repeatability and Reproducibility of ADC Measurements and MRI Signal Intensity Measurements of Bone Marrow in Monoclonal Plasma Cell Disorders: A Prospective Bi-institutional Multiscanner, Multiprotocol Study." Investigative radiology vol. (2021). doi: https://doi.org/10.1097/RLI.0000000000000838
Wennmann M, Thierjung H, Bauer F, Weru V, Hielscher T, Grözinger M, Gnirs R, Sauer S, Goldschmidt H, Weinhold N, Bonekamp D, Schlemmer HP, Weber TF, Delorme S, Rotkopf LT. Repeatability and Reproducibility of ADC Measurements and MRI Signal Intensity Measurements of Bone Marrow in Monoclonal Plasma Cell Disorders: A Prospective Bi-institutional Multiscanner, Multiprotocol Study. Invest Radiol. 2021 Nov 23; doi: 10.1097/RLI.0000000000000838. Epub 2021 Nov 23. PMID: 34839306.
Copy Download .nbib Format: NLM
International Multi-Site Initiative to Develop an MRI-Inclusive Nomogram for Side-Specific Prediction of Extraprostatic Extension of Prostate Cancer.

Cancers

Wibmer AG, Kattan MW, Alessandrino F, Baur ADJ, Boesen L, Franco FB, Bonekamp D, Campa R, Cash H, Catalá V, Crouzet S, Dinnoo S, Eastham J, Fennessy FM, Ghabili K, Hohenfellner M, Levi AW, Ji X, Løgager V, Margolis DJ, Moldovan PC, Panebianco V, Penzkofer T, Puech P, Radtke JP, Rouvière O, Schlemmer HP, Sprenkle PC, Tempany CM, Vilanova JC, Weinreb J, Hricak H, Shukla-Dave A.
PMID: 34071842
Cancers (Basel). 2021 May 27;13(11). doi: 10.3390/cancers13112627.

BACKGROUND: To develop an international, multi-site nomogram for side-specific prediction of extraprostatic extension (EPE) of prostate cancer based on clinical, biopsy, and magnetic resonance imaging- (MRI) derived data.METHODS: Ten institutions from the USA and Europe contributed clinical and side-specific...

Cite
Wibmer AG, Kattan MW, Alessandrino F, et al. International Multi-Site Initiative to Develop an MRI-Inclusive Nomogram for Side-Specific Prediction of Extraprostatic Extension of Prostate Cancer. Cancers (Basel). 2021;13(11)doi: 10.3390/cancers13112627.
Wibmer, A. G., Kattan, M. W., Alessandrino, F., Baur, A. D. J., Boesen, L., Franco, F. B., Bonekamp, D., Campa, R., Cash, H., Catalá, V., Crouzet, S., Dinnoo, S., Eastham, J., Fennessy, F. M., Ghabili, K., Hohenfellner, M., Levi, A. W., Ji, X., Løgager, V., Margolis, D. J., Moldovan, P. C., Panebianco, V., Penzkofer, T., Puech, P., Radtke, J. P., Rouvière, O., Schlemmer, H. P., Sprenkle, P. C., Tempany, C. M., Vilanova, J. C., Weinreb, J., Hricak, H., & Shukla-Dave, A. (2021). International Multi-Site Initiative to Develop an MRI-Inclusive Nomogram for Side-Specific Prediction of Extraprostatic Extension of Prostate Cancer. Cancers, 13(11), . https://doi.org/10.3390/cancers13112627
Wibmer, Andreas G, et al. "International Multi-Site Initiative to Develop an MRI-Inclusive Nomogram for Side-Specific Prediction of Extraprostatic Extension of Prostate Cancer." Cancers vol. 13,11 (2021). doi: https://doi.org/10.3390/cancers13112627
Wibmer AG, Kattan MW, Alessandrino F, Baur ADJ, Boesen L, Franco FB, Bonekamp D, Campa R, Cash H, Catalá V, Crouzet S, Dinnoo S, Eastham J, Fennessy FM, Ghabili K, Hohenfellner M, Levi AW, Ji X, Løgager V, Margolis DJ, Moldovan PC, Panebianco V, Penzkofer T, Puech P, Radtke JP, Rouvière O, Schlemmer HP, Sprenkle PC, Tempany CM, Vilanova JC, Weinreb J, Hricak H, Shukla-Dave A. International Multi-Site Initiative to Develop an MRI-Inclusive Nomogram for Side-Specific Prediction of Extraprostatic Extension of Prostate Cancer. Cancers (Basel). 2021 May 27;13(11). doi: 10.3390/cancers13112627. PMID: 34071842; PMCID: PMC8198352.
Copy Download .nbib Format: NLM
Drivers of Disinfection Byproduct Cytotoxicity in U.S. Drinking Water: Should Other DBPs Be Considered for Regulation?.

Environmental science & technology

Allen JM, Plewa MJ, Wagner ED, Wei X, Bokenkamp K, Hur K, Jia A, Liberatore HK, Lee CT, Shirkhani R, Krasner SW, Richardson SD.
PMID: 34910457
Environ Sci Technol. 2021 Dec 15; doi: 10.1021/acs.est.1c07998. Epub 2021 Dec 15.

This study reveals key disinfection byproduct (DBP) toxicity drivers in drinking water across the United States. DBPs, which are ubiquitous in drinking water, form by the reaction of disinfectants, organic matter, bromide, and iodide and are generally present at...

Cite
Allen JM, Plewa MJ, Wagner ED, et al. Drivers of Disinfection Byproduct Cytotoxicity in U.S. Drinking Water: Should Other DBPs Be Considered for Regulation?. Environ Sci Technol. 2021;doi: 10.1021/acs.est.1c07998.
Allen, J. M., Plewa, M. J., Wagner, E. D., Wei, X., Bokenkamp, K., Hur, K., Jia, A., Liberatore, H. K., Lee, C. T., Shirkhani, R., Krasner, S. W., & Richardson, S. D. (2021). Drivers of Disinfection Byproduct Cytotoxicity in U.S. Drinking Water: Should Other DBPs Be Considered for Regulation?. Environmental science & technology, . https://doi.org/10.1021/acs.est.1c07998
Allen, Joshua M, et al. "Drivers of Disinfection Byproduct Cytotoxicity in U.S. Drinking Water: Should Other DBPs Be Considered for Regulation?." Environmental science & technology vol. (2021). doi: https://doi.org/10.1021/acs.est.1c07998
Allen JM, Plewa MJ, Wagner ED, Wei X, Bokenkamp K, Hur K, Jia A, Liberatore HK, Lee CT, Shirkhani R, Krasner SW, Richardson SD. Drivers of Disinfection Byproduct Cytotoxicity in U.S. Drinking Water: Should Other DBPs Be Considered for Regulation?. Environ Sci Technol. 2021 Dec 15; doi: 10.1021/acs.est.1c07998. Epub 2021 Dec 15. PMID: 34910457.
Copy Download .nbib Format: NLM
Vicariance Events, not Areas, Should be Used in Biogeographical Analysis.

Cladistics : the international journal of the Willi Hennig Society

Hovenkamp P.
PMID: 34920640
Cladistics. 1997 Mar;13(1):67-79. doi: 10.1111/j.1096-0031.1997.tb00241.x.

Phylogenetic computer programs work by examining sequences of tree topologies, searching for those trees which yield minimal length. Rather than optimizing each tree from scratch, programs can use computational shortcuts to reduce the work required to compute each new...

Cite
Hovenkamp P. Vicariance Events, not Areas, Should be Used in Biogeographical Analysis. Cladistics. 1997;13(1):67-79doi: 10.1111/j.1096-0031.1997.tb00241.x.
Hovenkamp, P. (1997). Vicariance Events, not Areas, Should be Used in Biogeographical Analysis. Cladistics : the international journal of the Willi Hennig Society, 13(1), 67-79. https://doi.org/10.1111/j.1096-0031.1997.tb00241.x
Hovenkamp, P. "Vicariance Events, not Areas, Should be Used in Biogeographical Analysis." Cladistics : the international journal of the Willi Hennig Society vol. 13,1 (1997): 67-79. doi: https://doi.org/10.1111/j.1096-0031.1997.tb00241.x
Hovenkamp P. Vicariance Events, not Areas, Should be Used in Biogeographical Analysis. Cladistics. 1997 Mar;13(1):67-79. doi: 10.1111/j.1096-0031.1997.tb00241.x. PMID: 34920640.
Copy Download .nbib Format: NLM
Reply by Authors.

The Journal of urology

Klotz L, Pavlovich CP, Chin J, Hatiboglu G, Koch M, Penson D, Raman S, Oto A, Fütterer J, Serrallach M, Relle J, Lotan Y, Heidenreich A, Bonekamp D, Haider M, Tirkes T, Arora S, Macura KJ, Costa DN, Persigehl T, Pantuck AJ, Bomers J, Burtnyk M, Staruch R, Eggener S.
PMID: 33355501
J Urol. 2021 Mar;205(3):779. doi: 10.1097/JU.0000000000001362.03. Epub 2020 Dec 23.

No abstract available.

Cite
Klotz L, Pavlovich CP, Chin J, et al. Reply by Authors. J Urol. 2020;205(3):779doi: 10.1097/JU.0000000000001362.03.
Klotz, L., Pavlovich, C. P., Chin, J., Hatiboglu, G., Koch, M., Penson, D., Raman, S., Oto, A., Fütterer, J., Serrallach, M., Relle, J., Lotan, Y., Heidenreich, A., Bonekamp, D., Haider, M., Tirkes, T., Arora, S., Macura, K. J., Costa, D. N., Persigehl, T., Pantuck, A. J., Bomers, J., Burtnyk, M., Staruch, R., & Eggener, S. (2021). Reply by Authors. The Journal of urology, 205(3), 779. https://doi.org/10.1097/JU.0000000000001362.03
Klotz, Laurence, et al. "Reply by Authors." The Journal of urology vol. 205,3 (2021): 779. doi: https://doi.org/10.1097/JU.0000000000001362.03
Klotz L, Pavlovich CP, Chin J, Hatiboglu G, Koch M, Penson D, Raman S, Oto A, Fütterer J, Serrallach M, Relle J, Lotan Y, Heidenreich A, Bonekamp D, Haider M, Tirkes T, Arora S, Macura KJ, Costa DN, Persigehl T, Pantuck AJ, Bomers J, Burtnyk M, Staruch R, Eggener S. Reply by Authors. J Urol. 2021 Mar;205(3):779. doi: 10.1097/JU.0000000000001362.03. Epub 2020 Dec 23. PMID: 33355501.
Copy Download .nbib Format: NLM
Detection of Significant Prostate Cancer Using Target Saturation in Transperineal Magnetic Resonance Imaging/Transrectal Ultrasonography-fusion Biopsy.

European urology focus

Tschirdewahn S, Wiesenfarth M, Bonekamp D, Püllen L, Reis H, Panic A, Kesch C, Darr C, Heß J, Giganti F, Moore CM, Guberina N, Forsting M, Wetter A, Hadaschik B, Radtke JP.
PMID: 32660838
Eur Urol Focus. 2021 Nov;7(6):1300-1307. doi: 10.1016/j.euf.2020.06.020. Epub 2020 Jul 11.

BACKGROUND: Multiparametric magnetic resonance imaging (mpMRI) and targeted biopsies (TBs) facilitate accurate detection of significant prostate cancer (sPC). However, it remains unclear how many cores should be applied per target.OBJECTIVE: To assess sPC detection rates of two different target-dependent...

Cite
Tschirdewahn S, Wiesenfarth M, Bonekamp D, et al. Detection of Significant Prostate Cancer Using Target Saturation in Transperineal Magnetic Resonance Imaging/Transrectal Ultrasonography-fusion Biopsy. Eur Urol Focus. 2020;7(6):1300-1307doi: 10.1016/j.euf.2020.06.020.
Tschirdewahn, S., Wiesenfarth, M., Bonekamp, D., Püllen, L., Reis, H., Panic, A., Kesch, C., Darr, C., Heß, J., Giganti, F., Moore, C. M., Guberina, N., Forsting, M., Wetter, A., Hadaschik, B., & Radtke, J. P. (2021). Detection of Significant Prostate Cancer Using Target Saturation in Transperineal Magnetic Resonance Imaging/Transrectal Ultrasonography-fusion Biopsy. European urology focus, 7(6), 1300-1307. https://doi.org/10.1016/j.euf.2020.06.020
Tschirdewahn, Stephan, et al. "Detection of Significant Prostate Cancer Using Target Saturation in Transperineal Magnetic Resonance Imaging/Transrectal Ultrasonography-fusion Biopsy." European urology focus vol. 7,6 (2021): 1300-1307. doi: https://doi.org/10.1016/j.euf.2020.06.020
Tschirdewahn S, Wiesenfarth M, Bonekamp D, Püllen L, Reis H, Panic A, Kesch C, Darr C, Heß J, Giganti F, Moore CM, Guberina N, Forsting M, Wetter A, Hadaschik B, Radtke JP. Detection of Significant Prostate Cancer Using Target Saturation in Transperineal Magnetic Resonance Imaging/Transrectal Ultrasonography-fusion Biopsy. Eur Urol Focus. 2021 Nov;7(6):1300-1307. doi: 10.1016/j.euf.2020.06.020. Epub 2020 Jul 11. PMID: 32660838.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 49 entries